Copyright © 2002 Elsevier Science (USA). All rights reserved.
Regular Article
c-myc Suppression in Burkitt's Lymphoma Cells
Received 6 October 2001.
References and further reading may be available for this article. To view references and further reading you must purchase this article.
Abstract
The purpose of the study was to elucidate how DNA tetraplex (also referred to as G-quadruplex)-forming oligonucleotides mediate suppression of the human c-myc gene at the level of transcription initiation. A 22-base-long oligonucleotide, which is rich in guanines and folds into an intrastrand DNA tetraplex under physiological conditions, was administered to a Burkitt's lymphoma cell line overexpressing a (8:14) translocated c-myc allele. Administration of the oligonucleotide at nanomolar concentrations to the surrounding medium resulted in efficient cellular uptake, and was accompanied by a substantial concentration- and conformation-dependent decrease in growth rate. We discuss how c-myc transcription is initiated at the molecular level and speculate that the oligonucleotide exerts a dual effect on c-myc expression in vivo.
Author Keywords: anticancer drug; chromatin; G-quartet; gene therapy; promoter; telomere






E-mail Article
Add to my Quick Links

Cited By in Scopus (17)




